Sonova Holding (OTCMKTS:SONVY) Stock Now Rated “Moderate Buy” by Sell-Side Analysts

Sonova Holding (OTCMKTS:SONVY) has been given a consensus recommendation of “Moderate Buy” by the seven brokerages that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation, three have issued a buy recommendation and one has given a strong buy recommendation to the company.

SONVY has been the subject of several research analyst reports. UBS Group raised Sonova from a “hold” rating to a “buy” rating in a research note on Wednesday, July 22nd. Citigroup restated a “sell” rating on shares of Sonova in a research report on Friday, July 24th. Finally, The Goldman Sachs Group upgraded Sonova from a “hold” rating to a “buy” rating in a report on Thursday, October 8th.

Sonova Trading Up 0.7%

Shares of OTCMKTS:SONVY opened at $68.74 on Friday. The business’s 50 day simple moving average is $61.18 and its 200-day simple moving average is $53.20. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.75 and a quick ratio of 1.43. Sonova has a 12 month low of $42.26 and a 12 month high of $69.19.

About Sonova

Sonova Holding AG is a Switzerland-based hearing-care company that develops, manufactures and distributes solutions for people with hearing loss. Its portfolio includes hearing aids, cochlear implants, hearing implants, wireless communication products and related accessories and services.

The company markets products under several brands, including Phonak, Unitron and Advanced Bionics. Sonova also operates hearing-care businesses and retail networks that provide hearing assessments, device fitting, rehabilitation support and after-sales services.